Journal of The Academy of Clinical Microbiologists

Register      Login

VOLUME 16 , ISSUE 2 ( July-December, 2014 ) > List of Articles

Original Article

Interventional non-RCT study on the efficacy of Mupirocin versus Neomycin in the eradication of nasal carriers of Staphylococcus aureus in theatre staff

Farzana Thottathil Cheruvakkudy, John Sajan Kurian, Geetha Raveendran

Keywords : Carrier, Neomycin, Mupirocin

Citation Information : Cheruvakkudy FT, Kurian JS, Raveendran G. Interventional non-RCT study on the efficacy of Mupirocin versus Neomycin in the eradication of nasal carriers of Staphylococcus aureus in theatre staff. 2014; 16 (2):67-69.

DOI: 10.4103/0972-1282.144713

License: CC BY-NC-SA 4.0

Published Online: 15-07-2024

Copyright Statement:  Copyright © 2014; Wolters Kluwer India Pvt. Ltd.


Abstract

Aim: Nasal carriage of Staphylococcus aureus plays a pivotal role in the spread of nosocomial infections even in tertiary care centers. We decided to detect nasal carriage of S. aureus in our institution and eradicate it with local application of Mupirocin/Neomycin and to compare their efficiency. Materials and Methods: The study was conducted over a period of 12 months among 50 surgical theatre staff. In all, two nasal swabs were taken from each person at an interval of one week. Alternate nasal carriers identified were given Mupirocin/Neomycin for application in the anterior nares. A third swab was taken seven days after treatment. Observations and Result: Out of the fifty persons, 16 tested positive for S. aureus (32%). Out of the 16, two were Methicillin resistant Staphylococcus aureus (MRSA). All repeat swabs were negative after treatment with Mupirocin. However, 4% were not cured after treatment with Neomycin. Since the sample size is too small, an elaborate study should be conducted to include theatre staff of all speciality and this can confirm the promising role of Neomycin, as the percentage of resistance in this study appears negligible.


PDF Share
  1. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms and associated risks. Clin Microbial Rev 1997;10:505-20.
  2. Munoz P, Hortal J, Giannella M, Barrio JM, Rodriguez-Creixems M, Pérez MJ, et al. Nasal carriage of S aureus increases the risk of surgical site infection after major heart surgery. J Hosp Infect 2008;68:25-31.
  3. Casewell MW. The nose: An underestimated source of Staphylococcus aureus causing wound infection. J Hosp Infect 1998;40:S3-11.
  4. Darcy P. Eradication of nasal carriage of Staphylococcal aureus-is it cost effective. J Hosp Infect 1998;40:S31-7.
  5. Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, et al. Mupirocin And The Risk Of Staphylococcus Aureus Study Team. Intra nasal mupirocin to prevent post operative Staphylococcus aureus infections. N Eng J Med 2002;346:1871-7.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.